glucocorticoid injection alone. Subglottic or endobronchial stenoses should be managed by an otolaryngologist or pulmonologist, respectively, with expertise in management of these lesions. Immunosuppressive therapy is recommended for initial treatment of active inflammatory stenoses and usually comprises glucocorticoids and other agents Recommendation: For patients with GPA and mass lesions (e.g., orbital pseudotumor or masses of the parotid glands, brain, or lungs), we conditionally recommend